FCPM III Services’s RAPT Therapeutics RAPT Stock Holding History

FCPM III Services’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,833,333	Closed	-$62.1M	–	11
2025 Q4	$62.1M	Buy	1,833,333 +1,489,096	+433%	+$46.2M	8.14%	4
2025 Q3	$8.88M	Sell	344,237 -95,939	-22%	-$1.26M	1.77%	8
2025 Q2	$3.45M	Buy	+440,176	New	+$3.36M	0.93%	7

FCPM III Services's RAPT Position: Q1 2026 in Review

FCPM III Services sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 1,833,333 shares — an estimated $62.1M sold.

FCPM III Services first reported a position in RAPT in Q2 2025 and held it in 3 quarters. The position peaked at $62.1M in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

FCPM III Services reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
FCPM III Services sold 1,833,333 RAPT Therapeutics shares in Q1 2026, an estimated $62.1M.
FCPM III Services first reported a position in RAPT Therapeutics in Q2 2025 and held it in 3 quarters.
FCPM III Services's RAPT Therapeutics position peaked at $62.1M in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on FCPM III Services's 13F filing for Q1 2026, filed 15 May 2026.